Floor Statements

Mr. Speaker, I appreciate the gentleman's courtesy in allowing me to speak on this. I appreciate the leadership of Mr. Cohen. This is the culmination, hopefully, of years of struggle to try and end this barbaric practice.

There are those who are apologists for the industry. It shouldn't take this long, and repeated efforts, with hundreds of cosponsors, Congress after Congress after Congress. It has been my privilege to work with Mr. Whitfield from Kentucky, Ted Yoho, Kurt Schrader, our colleague from Oregon, and lately the leadership of Mr. Cohen, raising the banner and moving forward.

We should have zero tolerance for this barbaric practice. Forcing horses to be tortured, looking at the devices that they use to train them to have that distinctive gait. Concrete shoes.

We have had hearing after hearing here on Capitol Hill, and whenever we have an opportunity for people to be exposed to the abuses of this industry and see these barbaric practices, people marvel that we haven't been able to stop it.

Part of the problem is the self-regulation of the industry and that there isn't a sense of urgency to stop torturing these animals.

Mr. Speaker, I have been pleased to work repeatedly with colleagues on a bipartisan basis to stop it. I don't know what the compliance rate is, whether it is 96, 97, 90. The fact is, we are talking about hundreds of horses being tortured and for no good reason.

I strongly support the legislation from my colleague and the vast coalition that has been put in place to end this barbaric practice.

Some of the champions that have been involved in the past, like the Humane Society, have been there repeatedly, working to get the support, get the cosponsors, get it passed; but despite overwhelming support, despite a terrible record in protecting horses, it has taken far too long.

I am hopeful that this Congress will finally put an end to the barbaric practice, stop temporizing, stop apologizing for those who abuse horses and end this horrific practice once and for all.

Madam Speaker, is she declaring a conflict of interest on this legislation? Tongue-in-cheek. Excuse me.

We are all excited, awaiting the good news in terms of her family, and I think it is appropriate that we have this legislation on the floor today to help families all across the country.

The complexity that we found out in terms of the infant formula supply leaves us all scratching our heads in terms of all these elements.

I appreciate Congresswoman DelBene early zeroing in on this, mobilizing support, helping refine legislation, and enabling us to act very quickly.

This is an area that I hope that we will be able to have further conversations because I think there are issues in terms of healthcare supply chain and industrial policy.

It isn't, I think, quite so easy to snap our fingers and make sure that we are protecting this because it is a complicated matter. I know that at times, there are differences in terms of how much we should be interfering with the private sector and what they do.

I think this might be an area that we can work together to figure out ways that we can hit the appropriate balance, meet the need, not be too intrusive, but make sure we are not behind the curve.

The administration and Congress has made significant progress in this crisis, invoking the Defense Production Act, increasing the flexibility of WIC as was referenced, easing restrictions on imports to supply chain shortages, and enacting our Formula Act to temporarily suspend tariffs on infant formula.

We are expanding that work today to include formula base powder imports. Like finish formula, infant formula base powder imports face a substantial tariff when imported at a time when families need all the help they can get.

I don't want to take undue time, but I just want to commend our team working together, sending the appropriate signal, and hope it provides a foundation for other areas where we might be able to look for ways to thread that needle to be able to have partnerships with the private sector and with government to be able to make sure that we deal with these fragile supply chains.

One of the things the pandemic has demonstrated is how fragile our supply chains are. The notion, with so many industries dealing with just in time, puts them in a situation where the supply chain is so brittle that it produces results that horrify us all, like dumping milk on the ground because we couldn't get it to producers.

So I hope it leads to a broader conversation about things we can do to ease the pressures on supply chains and that this is an area where we can continue to work together and make a difference.

Madam Speaker, it is my honor and pleasure to extend my personal congratulations to an exceptional educator and outstanding constituent, Dr. Robert D. Kelly as he celebrates inauguration as the University of Portland's 21st President, first Black president, and first lay president.

Dr. Robert Kelly has more than 25 years of experience working in higher education. A 1994 graduate of Loyola University, Dr. Kelly served on the University's Board of Trustees from 2003 to 2017 while serving in key leadership roles at institutions including Union College, Loyola University Chicago, and Seattle University. He has been a champion for students in various roles from athletics to ministry, community service to equity and inclusion. Dr. Kelly received his Ph.D. in Education Policy, Planning, and Administration from the University of Maryland and his master's degree in Higher Education and Student Affairs Administration from the University of Vermont.

Dr. Kelly is assuming this leadership mantel at an instrumental time for the City of Portland, Multnomah County, and the State of Oregon. We are happy to have him and look forward to his leadership.

On behalf of Oregon's Third Congressional District: Welcome to Portland, Dr. Kelly. Go Pilots.

Madam Speaker, today I am pleased to introduce legislation to remove barriers to increase access to advance care planning in the Medicare program.

As we look for ways to lower health care spending, how we approach end of life care must be part of the conversation. When more than 90 percent of health care expenditures are spent on treating chronic conditions, it's clear that we shouldn't spend money on unwanted care and instead empower patients and families to think about these decisions before it is too late.

Improving Medicare coverage of voluntary discussions with providers about living wills, power of attorney, and other end-of-life treatment preferences can allow for these delicate and complex conversations to happen in a thoughtful manner.

Since 2009, I have introduced multiple pieces of legislation and built bipartisan support to improve Medicare coverage of these services to ensure that patients' wishes are respected and families are well prepared for this emotionally demanding time. In 2015, the Centers for Medicare and Medicaid Services (CMS) put forward a proposal, based on my Personalize Your Care Act, to allow physicians to bill for advance care planning. In the first year alone, these codes were used by more than 22,000 providers on behalf of more than 570,000 beneficiaries.

In the last two and a half years, we've seen tremendous loss and we must meet this moment. This legislation does just that by making this service free for beneficiaries and letting clinical social workers offer the service, allowing more patients to access this benefit.

I urge support for this legislation.

Madam Speaker, I came to Congress with a mission to make the federal government a better partner to local communities to make them more livable, healthy, and economically secure.

Last week, Congress made unprecedented progress on fulfilling the fundamental premise of this mission. The House and Senate both passed the Inflation Reduction Act, a historic investment in our nation's health, climate, and economy, including several provisions I authored to combat the climate crisis. President Biden is expected to sign the legislation into law this afternoon.

The Inflation Reduction Act will save Americans $288 billion on health care over the next ten years. Critically, it will allow Medicare to negotiate prescription drug prices, starting with the ten most expensive prescriptions. These negotiations will bring down costs for patients and taxpayers alike. When combined with new provisions capping Medicare beneficiaries' out-of pocket costs at $2,000 a year, the legislation will make an extraordinary difference in peoples' lives.

This package is the single largest investment in climate action in our nation's history. It will deliver $385 billion in energy and climate investments, including for electric vehicles, solar and wind energy, pollution reduction, and support for the vulnerable communities most impacted by environmental degradation. Long term extensions to the production and investment tax credits, including direct pay and transferability provisions, are critical components in ending our dependence on fossil fuels. I am also pleased that the investment tax credit was expanded to include energy storage projects, a key piece of the puzzle in delivering renewable energy to households at any time of day.

Combatting the climate crisis also means investing in infrastructure that is sustainable and efficient. Clean transportation incentives like an expanded electric vehicle credit for new and used vehicles, an expanded credit to charge e-bikes and e-scooters, and incentives to electrify commercial fleets will help accelerate the reduction of carbon emissions and fossil fuels in our day-to-day activities. Likewise, any construction projects in the 21st century must be made to meet the needs and goals of our communities. That's why I advocated for provisions in this package that make commercial buildings more energy efficient and sustainable.

While working families in our community and across the nation are struggling to pay for basic goods like gas, groceries, and rent, ultra- wealthy corporations are raking in record profits. Inflation is hitting Americans hard while many corporations aren't paying their fair share. This legislation will enact a corporate minimum tax of 15 percent. Currently, hundreds of the largest corporations in America pay substantially less, or nothing, in taxes. This provision ensures that large corporations will pay a minimum of 15 percent in taxes. The legislation also makes polluters pay by including my legislation reinstating the Superfund tax on crude oil.

It is no secret that the Internal Revenue Service (IRS) is outmatched. Decades of chronic underfunding have left the IRS understaffed and overburdened, allowing hundreds of billions of dollars in taxes owed to go uncollected. This legislation provides $3.2 billion for taxpayer services and $45.6 billion for enforcement, which the Congressional Budget Office estimates will raise more than $200 billion in additional revenue for the federal government. By investing in the IRS, we can finally close the ``tax gap'' between what people owe and what they end up paying.

The Inflation Reduction Act represents more than the sum of these individual provisions, it is proof that our system works and that the United States has the capacity to solve our most pressing challenges in the years ahead.

Mr. Speaker, I appreciate the opportunity to make one point. The extent to which this is a partisan bill is a result of selective memory and a willful refusal on the part of my Republican colleagues to work with us.

This legislation is replete with items that I am proud to have authored with Senator Grassley: The small energy wind tax credit; 30D in terms of electric vehicles; the 179 building tax credit. These are historically bipartisan in nature. There was a time when the Republicans used to work with us on that. They have chosen to move in the opposite direction, to their shame.

We are going to remedy that today.

Madam Speaker, I thank the chairman, and I appreciate his leadership and his courtesy.

Madam Speaker, this legislative package is something that refuses to die. It will reduce inflation, lower energy costs, and lower the cost of prescription drugs. But it is not just about inflation, it is about addressing the climate crisis and the crisis of confidence in government.

Last week, President Biden met with some of the foremost experts on the Presidency and American democracy to better understand the critical state that we are now in with the future of our democracy and how we avoid its destruction.

We have our moment of making American history now. It is our moment for the future of our planet, for our children and grandchildren, and ourselves.

I am pleased to have worked for over a decade on these provisions dealing with green energy, investment tax credits, energy efficiency in commercial buildings, and legislation to make polluters pay by reinstating the Superfund tax.

Seniors and working families will see significant savings by allowing Medicare to negotiate drug prices and capping the monthly cost of prescriptions, something the Republicans made illegal in 2004.

And critically, it takes steps to restore the ability of the IRS to function, closing the $400 billion tax gap and not making the American public pay for poor customer service because of their mindless attack on this important institution.

Because the Inflation Reduction Act represents more than the sum of these individual provisions, it is proof that our system works and that the United States has the capacity to solve our most pressing challenges in the years ahead just when we need it most.

Madam Speaker, today I introduced the Afghan Adjustment Act. This legislation would establish a pathway to permanent legal status for newly arrived Afghans displaced at the end of the 20- year U.S. mission in Afghanistan.

Without this legislation, the tens of thousands of Afghans who were admitted to the United States under temporary humanitarian parole, including those who supported the U.S. mission in Afghanistan during the past 20 years, face tremendous legal uncertainty. These Afghans can only pursue permanent legal status in the United States through the asylum system or, for those who are eligible, the Afghan Special Immigrant Visa (SIV) program. Both paths have substantial backlogs, long processing times, and logistical obstacles for these individuals.

I first became involved in the cause of Afghan allies nearly 15 years ago after being contacted by a social studies class from Portland's Lincoln High School. Those discussions prompted me to work with former Senators John McCain and Ted Kennedy to create the Iraqi and Afghan Special Immigrant Visa (SIV) programs. Ever since, I have continued to work to strengthen these critical programs and provide a permanent, safe outcome for the brave men and women who risked their lives to help the United States.

Congress must keep our commitment to provide safe, legal refuge to the those who willingly put their lives on the line to support U.S. mission in Afghanistan. Following previous wartime evacuations and humanitarian crises, including the Vietnam War and the rise of Castro in Cuba, Congress has provided a legal adjustment process for those evacuated to the United States and should do so once again, without delay.

I look forward to working with my co-leads, Representatives Peter Meijer, Jerry Nadler, Adam Kinzinger, Zoe Lofgren, Mariannette Miller- Meeks, Jason Crow, Fred Upton, and Scott Peters in the House and Senators Amy Klobuchar, Lindsey Graham, Chris Coons, Roy Blunt, Richard Blumenthal, and Lisa Murkowski in the Senate to enact this legislation and finally establish a path forward for Afghans admitted to the United States on humanitarian status.

Mr. Speaker, today I will vote to pass the Medical Marijuana and Cannabidiol Research Expansion Act. This legislation would remove barriers for research into cannabis and facilitate access to an increased supply of cannabis for research purposes.

The cannabis laws in this country are broken, including our laws that govern cannabis research. Because cannabis is a Schedule I substance, researchers must jump through hoops and comply with onerous requirements just to do basic research on the medical potential of the plant.

The Medical Marijuana and Cannabidiol Research Expansion Act amends the Controlled Substances Act to streamline the registration process and expands opportunity for our researchers to investigate the potential and impacts of cannabis.

My partners in the House and Senate and I worked closely with experts in Congress and the Department of Health and Human Services (HHS) to ensure this legislation will expand cannabis research, not restrict it. Specifically, the use of ``practitioners'' includes ``NIH-funded researchers,'' according to feedback from HHS. This ensures that this legislation will not restrict researchers already considered entities eligible to conduct research under the Controlled Substances Act. H.R. 8454 is designed to streamline and broaden access to researching marijuana.

Enacting this legislation will be an important step forward in making the federal government a real partner in the path forward on cannabis. In addition to this legislation, we must continue to advance banking access for cannabis businesses; prioritize expungements, clemencies, and resentencing for cannabis convictions; make robust investments in cannabis research; develop accurate tests for impairment; ensure our veterans can access medical cannabis; and invest in communities targeted in the failed war on drugs.

The Medical Marijuana and Cannabidiol Research Expansion Act demonstrates the power of good faith bipartisan engagement on cannabis policy and the opportunity of this moment to enact laws our communities need.

I look forward to working with Senators Dianne Feinstein, Brian Schatz, and Chuck Grassley and my co-lead Representative Andy Harris to enact this legislation and expand our Nation's cannabis research capabilities.

Madam Speaker, today I introduced the Right to Try Clarification Act. This legislation would expand access to life- changing treatments by including Schedule I substances that have completed phase 1 clinical studies in the Right to Try Act.

Oregon has a long legacy of ensuring that end-of-life patients have access to the full spectrum of treatment options to alleviate their condition and improve their quality of life. Patients and doctors deserve to discuss treatments--including psilocybin--that researchers find provide immediate and sustained relief from pain, anxiety, and depression for people battling terminal illness.

Federal restrictions have obstructed access to end-of-life care for too long, this legislation will change that and ensure that all patients have the Right to Try.

The psychedelics laws in this country are broken, including our laws governing patients' access to new and promising end-of-life care. Forty-one state legislations have passed Right to Try laws, in addition to our federal Right to Try statute, to allow terminally ill patients access to treatments, including psilocybin, that are still in investigational stages. Both psilocybin and MDMA have demonstrated tremendous care potential in phase 1 and phase 2 clinical trials.

The Drug Enforcement Agency, however, has refused to accommodate Right to Try laws, denying terminally ill patients their freedom to elect their preferred treatments. These patients deserve to be able to discuss and pursue treatments with their doctors that researchers are finding provide immediate, substantial, and sustained relief from anxiety and depression for people battling terminal illness. That is why the Right to Try Clarification Act is necessary to ensure patients have the Right to Try these treatment options.

I look forward to working with Senators Cory Booker and Rand Paul and my co-leads Representatives Nancy Mace, Madeline Dean, Andy Biggs, and Luis Correa to enact this legislation and clarify and strengthen the Right to Try.

Madam Speaker, today I introduced the Bicycles for Rural African Transport Act. Transportation access in the developing world is limited. In sub-Saharan Africa, more than seventy percent of people rely on walking as their primary mode of transportation. For these individuals access to a bicycle is revolutionary.

Bicycles can be impactful tools for effective foreign aid and international economic development.

Low-cost, high-impact investments in bicycles will allow us to use existing foreign aid more effectively. Many developing-world rural populations suffer from time poverty, which limits opportunities to access education, healthcare, employment and job training opportunities, and markets. By reducing time poverty, bicycle access significantly improves school attendance for rural girls. In one trial, girls with bicycles were 19 percent less likely to drop out of school.

In recent years, USAID has conducted a small rural mobility program to study the bicycle's development impacts. In Tanzania in 2019, USAID donated 2,160 bicycles to health care workers as part of AIDS treatment efforts, allowing the workers to reach more patients and reducing AIDS transmission in the area. In Malawi in 2020, USAID established a revolving loan fund to finance bicycles for workers on a sugar cane cooperative, reducing their commute times and increasing productivity.

USAID's work on this program has clearly demonstrated the value of bicycles for rural transportation in developing nations. This legislation authorizes a permanent rural mobility program at USAID which will promote rural, sub-Saharan communities' access to services and opportunities through affordable, fit-for-purpose bicycles. This more systematic approach will allow USAID to maximize the potential impact of bicycle projects and ensure the United States continues utilizing this simple, revolutionary development tool.

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 8351) to amend the Harmonized Tariff Schedule of the United States to suspend temporarily rates of duty on imports of certain infant formula products, and for other purposes.

Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material on the bill under consideration.

Madam Speaker, I yield myself such time as I may consume.

The news about supply chain disruptions have filled the news, but none is more compelling and urgent for communities across America than facing challenges due to the infant formula shortage. This is an urgent issue for our families.

Between supply chain issues due to the pandemic and the closure of a Michigan infant formula plant, out-of-stock rates have reached perilous levels. The out-of-stock rate was 31 percent in mid-April and rose to 90 percent in 10 States by the end of May. In my State, Oregon, we faced an out-of-stock rate higher than 85 percent.

While these numbers alone tell a horrific story, there is no number that can capture the fear and frustration felt by families who are searching for formula to serve their babies. As a parent and grandparent, I can assure you that there is nothing as anxiety- and anger-

inducing as not being able to properly care for your child.

I have heard stories of families going store to store or posting on social media asking for help as they try to find the formula their family needs. Families have enough to worry about without worrying about how to feed their baby.

The Federal Government must provide the support needed to help these children and families and explore every possible option. This administration and Congress has made significant progress by invoking the Defense Production Act, increasing flexibility for the WIC program, and easing restrictions on imports to fill supply chain shortages.

While the FDA has exercised enforcement discretion to increase imports, imported infant formula remains subject to high tariffs. These tariffs, which increase the cost of the formula imports by an estimated 27 percent, only exaggerate the suffering families face at this time.

It is unacceptable that families would be taxed on a product that they need and have no other way of getting in the midst of this crisis. Our Ways and Means Trade Subcommittee is committed to leveraging our jurisdiction to reduce these costs.

I especially appreciate my colleague Suzan DelBene for her partnership and leadership on this legislation. She was integral to this effort, and we wouldn't be here today without her.

The Formula Act reaffirms Congress' constitutional authority to regulate commerce from foreign nations by temporarily suspending tariffs on imported infant formula through the end of this year. This change should help make formula more affordable and accessible to families in every State.

I am grateful for the support of Chairman Neal; Ranking Member Brady; Ranking Member Smith, who is managing the bill for the Republicans; and the Ways and Means Committee in bringing this bipartisan legislation to the floor today.

Madam Speaker, I urge my colleagues to support the legislation, and I reserve the balance of my time.

Madam Speaker, I yield such time as she may consume to the gentlewoman from Washington (Ms. DelBene), a committee member and a leader on this issue.

Madam Speaker, I yield 3 minutes to the gentleman from Michigan (Mr. Kildee), a senior member of the Ways and Means Committee.

Madam Speaker, I yield 2 minutes to the gentlewoman from Texas (Ms. Jackson Lee).

Madam Speaker, I yield myself such time as I may consume.

I appreciate the partnership with my good friend, Mr. Smith. We have been able to move this expeditiously. I do appreciate his observation that there are challenges that we meet, and we would hope that our government and the various agencies that are involved are able to respond quickly. That, of course, is something that we need to empower them to do, these partnerships.

Sometimes there is a little tension about the role and nature of government agencies, but this is an example, admittedly, where we want to get ahead of the curve, and the powers that agencies have can be used constructively.

I am pleased that our committee, for example, sprang into action dealing with the invasion of Ukraine by Russia to suspend tariff advantages for Russia, and we moved that quickly on a bipartisan basis. Particularly in this case we have 26 members of the Ways and Means Committee who are cosponsoring this legislation, and it was able to move quickly.

Unlike what often happens with things we pass in the House that linger in the Senate, it looks like the Senate is poised to be able to act quickly in response to our action here today.

So I hope we come together. I hope we have a unanimous vote that would suspend this 27 percent additional cost on families struggling to meet the needs of their children. I hope that we can continue to look at areas where we need to refine tools to make sure that things like this don't happen again and we work together to try to hit the right balance.

In the meantime, I think we have hit the right balance with this legislation. I appreciate the partnership, and I look forward to its passage today.

Madam Speaker, I yield back the balance of my time.

Madam Speaker, I want to begin to acknowledge the pain that people have experienced in the wake of being stripped of their rights and being thrust into legal limbo.

We have already seen the impact this horrific decision has had on increased wait times in clinics, and doctors forced to consult with lawyers because of State restrictions, while patients may be dying on operating tables.

The barbaric treatment of the 10-year-old child, a victim of rape, made into a media circus, and the prospect of the doctor who provided her care being subjected to legal action.

We know the Supreme Court has put us all on the wrong side of history. These appalling stories reinforce the fact that denying fundamental healthcare has dire and unforeseen circumstances far beyond the slogans that have been bandied around.

I believe it is our duty to take responsibility to make progress in even these difficult circumstances to provide a path forward. This legislation does that.

We owe it to American families to make progress, to protect them and improve access to this right, and spare them government intrusion into the most sensitive and personal matters. Our rage must be productive.

Madam Speaker, today I introduced the Veterans Equal Access Act. This legislation would provide equal access to state-legal medical marijuana for veterans participating in Department of Veterans Affairs (VA) health care by ending the harmful VA prohibition on doctors and healthcare providers giving opinions or recommendations on or completing forms for state-legal medical marijuana programs.

The cannabis laws in this country are broken, including our laws that govern veterans' access to medical cannabis. Many veterans report using cannabis for medical purposes as a substitute for prescription drugs. The VA National Center for Post-Traumatic Stress Disorder (PTSD) has acknowledged that veterans use cannabis to relieve symptoms of PTSD, and that in many states, PTSD is a qualifying condition for enrollment in medical cannabis programs.

Most states with state-legal medical cannabis programs require some sort of recommendation or approval from a medical provider for patients to enroll in the program. However, VA policy prevents VA physicians and care providers from any participation, including helping with the required paperwork or forms.

This forces veterans to seek care outside of the VA system to receive medical cannabis recommendations, which can interrupt continuity of care, lead to mistakes or gaps in care, and require veterans to pay out of pocket for addition physician visits. VA physicians should not be denied the ability to offer a recommendation that they think may meet the needs of their patients.

Veterans should not be forced outside the VA system to seek treatment that is legal in their state.

The Veterans Equal Access Act would allow VA doctors and healthcare providers to give their opinions or recommendations on medical cannabis and to complete forms in compliance with state-legal medical marijuana programs.

I look forward to working with my co-lead, Representative Brian Mast, and my colleagues in the House and Senate to enact this legislation and provide equal access to state-legal medical cannabis for our veterans participating in VA health care.

Madam Speaker, today I am pleased to introduce the Affordable and Accessible Infant Formula Act, legislation to temporarily suspend tariffs on imported infant formula.

As we've all seen, families across the country have been facing a devastating infant formula shortage. Between the closure of an Abbott plant in Michigan in February and general supply chain struggles, out- of-stock rates for formula have been growing exponentially. At the end of May, ten states and fourteen metropolitan areas have out-of-stock rates higher than 90 percent. To make matters worse, restarting formula production at Abbott's Michigan plan was further delayed after flooding from severe storms.

The Biden-Harris Administration has acted swiftly to respond to the crisis. In May, the Food and Drug Administration (FDA) took unprecedented action to temporarily exercise enforcement discretion to increase infant formula in the United States. As of June 10, the Biden- Harris Administration has secured commitments to import 130.7 million bottles of formula.

The FDA's actions have allowed formula to be imported from around the world including Germany, Switzerland, and England. However, infant formula faces a substantial tariff when imported from countries without a Free Trade Agreement or that are not part of a preference program. As infant formula is imported into the United States during this period of an infant formula shortage, tariffs will increase the cost of the formula by approximately 27 percent on average.

At a time of unprecedented crisis, the federal government should swiftly seek to remove any barriers that exacerbate the crisis. The FDA has done this by exercising enforcement discretion. Now, it is up to Congress to temporarily suspend the tariffs on imported infant formula so that imported formula is affordable for working families. Suspending these tariffs for the duration of the FDA's current easing import restrictions will lower the cost of infant formula at a time when working families and single parents are struggling.

I urge my colleagues to support this bipartisan legislation and bring relief to families across the country.